Group 1 - The core point of the article is that Dongfang Electronics (SZ 000682) held a temporary board meeting on October 23, 2025, to review the proposal for the company's Q3 2025 report [1] - For the first half of 2025, Dongfang Electronics reported that 98.06% of its revenue came from the automation industry, while 1.94% came from non-automation sectors [1] - As of the report, Dongfang Electronics has a market capitalization of 15.9 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing deals this year, indicating a booming secondary market in biomedicine [1] - A conversation with Lu Gang, a partner at Chuangdong Investment, reveals that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]
东方电子:10月23日召开董事会会议